The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Blood products are those biologicals derived from plasma or obtained by recombinant technologies. The regular blood biologicals which be applied in clinic at present mainly contain albumin, immunoglobulins and coagulation factors. The five-year forecast for Chinese blood products market shows an impressive Compound Annual Growth Rate (CAGR) of 18.9 percent driven by increased demand, according to a new report published by Gen Consulting Company.
The report covers forecast and analysis for the blood products market on a country wise and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the blood products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Chinese blood products market.
The report has been prepared based on the synthesis, analysis, and interpretation of information about the Chinese blood products market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.
On the basis of product types, the report provides separate comprehensive analytics for Chinese albumin, immunoglobulins and coagulation factors market. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in Chinese blood products market.
Key Product Types
- Human Albumin
- Intravenous Immuneglobulin/IVIG
- Rabies Immunoglobulin (RIG)
- Hepatitis B Immunoglobulin (HBIG)
- Tetanus Immuneglobulin (TIG)
- Coagulation Factor VIII
- Prothrombin Complex Concentrates (PCC)
- North China
- East China
- South China
- Central China
- CSL Behring
- Guangming Group
- Hansen Medical
- Hualan Bio
- Octapharma AG
- Shanghai RAAS
Key Questions Answered in this Report
- What will the market size be in 2022?
- What are the key factors driving the Chinese blood products market?
- What are the challenges to market growth?
- Who are the key players in the blood products market?
- What are the market opportunities and threats faced by the key players?